2006
DOI: 10.1161/circulationaha.105.613034
|View full text |Cite
|
Sign up to set email alerts
|

Cell Therapy for Acute Myocardial Infarction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
32
0

Year Published

2006
2006
2015
2015

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(32 citation statements)
references
References 40 publications
0
32
0
Order By: Relevance
“…These parameters, however, cannot be readily obtained in the clinical setting in contrast to preclinical animal studies since extensive histologic analysis of myocardial tissue after cell transplantation cannot be performed in patients. Therefore, the development of noninvasive imaging approaches to monitor the fate of implanted stem cells is needed and may help in successful translation of stem cell therapies to patients (18)(19)(20)(21)(22). Several different imaging approaches for visualizing stem cell fate in the heart are currently under investigation, including magnetic resonance (MR) imaging, optical imaging, and PET.…”
Section: Molecular Imaging: Imaging Gene Expression In Human Mesenchymentioning
confidence: 99%
See 1 more Smart Citation
“…These parameters, however, cannot be readily obtained in the clinical setting in contrast to preclinical animal studies since extensive histologic analysis of myocardial tissue after cell transplantation cannot be performed in patients. Therefore, the development of noninvasive imaging approaches to monitor the fate of implanted stem cells is needed and may help in successful translation of stem cell therapies to patients (18)(19)(20)(21)(22). Several different imaging approaches for visualizing stem cell fate in the heart are currently under investigation, including magnetic resonance (MR) imaging, optical imaging, and PET.…”
Section: Molecular Imaging: Imaging Gene Expression In Human Mesenchymentioning
confidence: 99%
“…Furthermore, conflicting reports on the clinical benefit in patients with coronary artery disease following cell transplantation have raised several questions, including which subpopulation of patients with coronary artery disease may benefit most from which cell type implanted through which delivery approach in the heart (14)(15)(16)(17). The development of objective and quantitative noninvasive (imaging) approaches for tracking stem cell fate, including stem cell location, survival, engraftment, and differentiation, may help in better understanding stem cell biology and may lead to better patient stratification and eventual successful implementation of cardiac stem cell therapy into the clinic (18)(19)(20)(21)(22).…”
mentioning
confidence: 99%
“…The road from vascular biological principles underpinning the promise of cell therapy to an approvable therapy for individuals with CLI will require us to sustain optimism, share data generously, and evaluate risk and benefit diligently. 21 When this is accomplished for CLI, this challenging manifestation of PAD will no longer be an orphan disease for which there is no effective medical treatment.…”
Section: Resultsmentioning
confidence: 99%
“…They also explained improvement as an endocrine or exocrine effect, or regarded progenitor cells as inflammatory cells when in the myocardium. 17 In the myocardium, monocyte-derived macrophages and mast cells may also produce cytokines and growth factors necessary for fibroblast proliferation and neovascularization, leading to effective repair and scar formation. 18 Generally, circulating mononuclear cells are an important source of inflammatory cytokines in the plasma and myocardium.…”
Section: Discussionmentioning
confidence: 99%